Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001214659-23-007582
Filing Date
2023-05-19
Accepted
2023-05-19 17:00:48
Documents
7

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 10 wsc13da10.htm SC 13D/A 51920
2 GRAPHIC ex9-001.jpg GRAPHIC 65869
3 GRAPHIC ex9-002.jpg GRAPHIC 59795
4 GRAPHIC ex9-003.jpg GRAPHIC 78859
5 GRAPHIC ex9-004.jpg GRAPHIC 52654
6 GRAPHIC ex9-005.jpg GRAPHIC 39214
7 GRAPHIC ex9-006.jpg GRAPHIC 48660
  Complete submission text file 0001214659-23-007582.txt   529397
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Enochian Biosciences Inc (Subject) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13D/A | Act: 34 | File No.: 005-86428 | Film No.: 23941269
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8581 SANTA MONICA BLVD LOS ANGELES CA 90069
Business Address
William Anderson Wittekind (Filed by) CIK: 0001753085 (see all company filings)

Type: SC 13D/A